Shares of Validus Holdings, Ltd. (NYSE:VR) have been assigned an average recommendation of “Hold” from the eleven brokerages that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $54.83.
A number of research analysts have issued reports on VR shares. Zacks Investment Research cut shares of Validus from a “hold” rating to a “strong sell” rating in a report on Thursday, September 28th. UBS decreased their price target on shares of Validus from $50.00 to $48.00 and set a “neutral” rating for the company in a report on Monday, October 2nd. TheStreet cut shares of Validus from a “b” rating to a “c+” rating in a report on Wednesday, October 11th. ValuEngine raised shares of Validus from a “sell” rating to a “hold” rating in a report on Friday, October 20th. Finally, BidaskClub cut shares of Validus from a “sell” rating to a “strong sell” rating in a report on Friday, August 18th.
Validus (VR) traded down $0.32 during midday trading on Thursday, hitting $46.16. 933,701 shares of the company’s stock were exchanged, compared to its average volume of 616,918. Validus has a fifty-two week low of $41.15 and a fifty-two week high of $58.76. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.95 and a quick ratio of 0.95.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Investors of record on Friday, December 15th will be issued a dividend of $0.38 per share. The ex-dividend date is Thursday, December 14th. This represents a $1.52 annualized dividend and a dividend yield of 3.29%. Validus’s dividend payout ratio (DPR) is presently -233.84%.
In related news, President Kean Driscoll sold 6,875 shares of the firm’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $50.30, for a total transaction of $345,812.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Lixin Zeng sold 26,136 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $52.10, for a total transaction of $1,361,685.60. Following the transaction, the chief executive officer now directly owns 57,855 shares of the company’s stock, valued at approximately $3,014,245.50. The disclosure for this sale can be found here. Company insiders own 2.33% of the company’s stock.
Institutional investors have recently modified their holdings of the stock. IFP Advisors Inc raised its holdings in shares of Validus by 14.0% during the second quarter. IFP Advisors Inc now owns 2,154 shares of the insurance provider’s stock worth $112,000 after purchasing an additional 265 shares during the last quarter. SG Americas Securities LLC purchased a new position in shares of Validus during the second quarter worth $116,000. Zions Bancorporation purchased a new position in shares of Validus during the third quarter worth $116,000. The Manufacturers Life Insurance Company grew its position in Validus by 10.1% during the second quarter. The Manufacturers Life Insurance Company now owns 2,382 shares of the insurance provider’s stock valued at $124,000 after buying an additional 219 shares during the period. Finally, BNP Paribas Arbitrage SA grew its position in Validus by 93.7% during the second quarter. BNP Paribas Arbitrage SA now owns 2,650 shares of the insurance provider’s stock valued at $138,000 after buying an additional 1,282 shares during the period. 96.35% of the stock is owned by hedge funds and other institutional investors.
Validus Company Profile
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.